Form 4 for EWTX Edgewise Therapeutics, Inc.
Accepted 2023-12-28 00:00:00 ET · period of report 2023-12-26 · accession 0001562180-23-008571 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-28 | 2023-12-26 | EWTX | Russell Alan J | CSO, Dir | S - Sale | $9.33 | -172.6K | 3,606 | -98% | -$1.61M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-26 | S | D | 172,585 | $9.33 | 3,606 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $9.155 USD to $9.595 USD; the price reported above reflects the weighted average sale price. |